TipRanks
Viridian Therapeutics (DE:1S1)
FRANKFURT:1S1
Germany Market

Viridian Therapeutics (1S1) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Neutral
5Bullish
1Neutral
6Bearish
Viridian Therapeutics’s (1S1) Moving Averages Convergence Divergence (MACD) indicator is 0.07, suggesting Viridian Therapeutics is a Buy.
Viridian Therapeutics’s (1S1) 20-Day exponential moving average is 19.41, while Viridian Therapeutics’s (1S1) share price is €20.6, making it a Sell.
Viridian Therapeutics’s (1S1) 50-Day exponential moving average is 18.63, while Viridian Therapeutics’s (1S1) share price is €20.6, making it a Buy.

Viridian Therapeutics (1S1) Pivot Points

Sep 18, 2026, 10:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
18.10
18.10
18.10
18.10
18.10
18.10
18.10
Fibonacci
18.10
18.10
18.10
18.10
18.10
18.10
18.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Viridian Therapeutics (1S1) Moving Averages

Sep 18, 2026, 10:59 AM
Period
Simple
Exponential
MA5
19.10Neutral
19.03Buy
MA10
19.39Sell
19.30Sell
MA20
19.91Sell
19.41Sell
MA50
18.54Buy
18.63Buy
MA100
16.53Buy
18.15Buy
MA200
19.99Sell
19.76Sell
Viridian Therapeutics’s (1S1) 10-Day exponential moving average is 19.30, while Viridian Therapeutics’s (1S1) share price is €20.6, making it a Sell.
Viridian Therapeutics’s (1S1) 100-Day exponential moving average is 18.15, while Viridian Therapeutics’s (1S1) share price is €20.6, making it a Buy.
Viridian Therapeutics’s (1S1) stock price is €20.6 and Viridian Therapeutics’s (1S1) 50-day simple moving average is 18.54, creating a Buy signal.
Viridian Therapeutics’s (1S1) stock price is €20.6 and Viridian Therapeutics’s (1S1) 100-day simple moving average is 16.53, creating a Buy signal.
Viridian Therapeutics’s (1S1) stock price is €20.6 and Viridian Therapeutics’s (1S1) 200-day simple moving average is 19.99, creating a Sell signal.

Viridian Therapeutics (1S1) Technical Indicators

Sep 18, 2026, 10:59 AM
Name
Value
Implied Action
RSI (14)
48.33
Neutral
STOCH (9,6)
19.61
Buy
STOCHRSI (14)
13.33
Buy
MACD (12,26)
0.07
Buy
ADX (14)
16.02
Buy
Williams %R
-60.00
Buy
CCI (14)
-99.47
Neutral
ATR (14)
0.40
-
Ultimate Oscillator
40.08
Neutral
ROC
-7.28
Sell
Viridian Therapeutics’s (1S1) Relative Strength Index (RSI) is 48.33, creating a Neutral signal.
Viridian Therapeutics’s (1S1) Trend Strength Indicator (ADX) is 16.02, creating a Buy signal.
Viridian Therapeutics’s (1S1) Commodity Channel Index (CCI) is -99.47, creating a Neutral signal.
Viridian Therapeutics’s (1S1) Price Rate of Change (ROC) is -7.28, creating a Sell signal.

FAQ

Is 1S1 a Buy, Hold, or Sell?
Based on 1S1’s technical indicators, 1S1 is a Hold.
    What is 1S1’s RSI (14)?
    1S1’s RSI (14) is 48.33, which suggests 1S1 is a Neutral.
      What is 1S1’s MACD?
      1S1’s MACD is 0.07, which suggests 1S1 is a Buy.
        What is 1S1’s 5-day moving average?
        1S1’s 5-day moving average is 19.10, which suggests 1S1 is a Neutral.
          What is 1S1’s 20-day moving average?
          1S1 20-day moving average is 19.91, which suggests 1S1 is a Sell.
            What is 1S1’s 50-day moving average?
            1S1’s 50-day moving average is 18.54, which suggests 1S1 is a Buy.
              What is 1S1’s 200-day moving average?
              1S1’s 200-day moving average is 19.99, which suggests 1S1 is a Sell.
                What is 1S1’s Williams % R (14)?
                1S1’s Williams % R (14) is -60.00, which suggests 1S1 is a Buy.
                  What is 1S1’s CCI (14)?
                  1S1’s CCI (14) is -99.47, which suggests 1S1 is a Neutral.
                    What is the share price of Viridian Therapeutics?